DIFFUSE GASTRIC CANCER
Clinical trials for DIFFUSE GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE GASTRIC CANCER trials appear
Sign up with your email to follow new studies for DIFFUSE GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare breast cancer
Disease control CompletedThis study tested a combination of two drugs, crizotinib and fulvestrant, in 33 people with advanced lobular breast cancer that had lost a protein called E-cadherin. It also tested crizotinib alone in people with diffuse gastric cancer, triple-negative lobular breast cancer, or o…
Matched conditions: DIFFUSE GASTRIC CANCER
Phase: PHASE2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental cancer drug PTX-100 enters early human testing
Disease control CompletedThis early-phase trial tested a new drug called PTX-100 in 25 people with advanced cancers like multiple myeloma, lymphoma, and certain solid tumors. The goal was to find safe doses and understand how the drug behaves in the body. Participants received the drug by IV for five day…
Matched conditions: DIFFUSE GASTRIC CANCER
Phase: PHASE1 • Sponsor: Prescient Therapeutics, Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:35 UTC